Market Capitalization of Molbio Diagnostics Ltd
From Blinkx's GPT
Key Highlights
- The Latest Trading Price of Molbio Diagnostics Ltd is ₹ 1036 as of 17 Aug 15:53 .
Molbio Diagnostics Ltd
NSE: MOLBIO
Share Price
Market Price of Molbio Diagnostics Ltd
1M
1Y
3Y
5Y
SWOT Analysis Of Molbio Diagnostics Ltd
BlinkX Score for Molbio Diagnostics Ltd
Asset Value vs Market Value of Molbio Diagnostics Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Molbio Diagnostics Ltd
Historical P/E Ratio of Molbio Diagnostics Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Molbio Diagnostics Ltd
Historical Revenue of Molbio Diagnostics Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Molbio Diagnostics Ltd
Historical EBITDA of Molbio Diagnostics Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Molbio Diagnostics Ltd
Historical Net Profit of Molbio Diagnostics Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Molbio Diagnostics Ltd
Dividend Payout Over Time
About Molbio Diagnostics Ltd
- Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
- Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
- The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
- Bigtec Innovations Private Limited got merged with the Company in 2015.
Molbio Diagnostics Ltd News Hub
Molbio Diagnostics IPO subscribed 83%
The initial public offer of Molbio Diagnostics received bids for 67,67,496 shares as against 81,58,5
Read more
10 Aug 26
Molbio Diagnostics IPO subscribed 70.26 times
The initial public offer of Molbio Diagnostics received bids for 57,32,14,536 shares as against 81,5
Read more
12 Aug 26
Molbio Diagnostics gains on debut
The stock debuted at Rs 980, marking a premium of 21.44% to the issue price. So far, the stock has h
Read more
17 Aug 26
Shares of Molbio Diagnostics list in B group
The equity shares of Molbio Diagnostics (Scrip Code: 544866) are listed effective 17 August 2026 and
Read more
17 Aug 26
